APA (7th ed.) Citation

CW, H., S, S., SN, P., E, O., JS, A., & KL, S. (2023). Physiologically-based pharmacokinetic modelling to predict intragastric rifabutin concentrations in the treatment of Helicobacter pylori infection. Alimentary pharmacology & therapeutics, 58(2), 159. https://doi.org/10.1111/apt.17526

Chicago Style (17th ed.) Citation

CW, Howden, Shah S, Pendse SN, Offman E, Almenoff JS, and Sheldon KL. "Physiologically-based Pharmacokinetic Modelling to Predict Intragastric Rifabutin Concentrations in the Treatment of Helicobacter Pylori Infection." Alimentary Pharmacology & Therapeutics 58, no. 2 (2023): 159. https://doi.org/10.1111/apt.17526.

MLA (9th ed.) Citation

CW, Howden, et al. "Physiologically-based Pharmacokinetic Modelling to Predict Intragastric Rifabutin Concentrations in the Treatment of Helicobacter Pylori Infection." Alimentary Pharmacology & Therapeutics, vol. 58, no. 2, 2023, p. 159, https://doi.org/10.1111/apt.17526.